"I turned $15,253 into $1,613,442 trading Biotech stocks… without setting foot on Wall Street."

Want to learn how I did it?

Best for Active Traders

Biotech Catalyst Swing Trading

$399 / quarterly

Each week you’ll receive a watch list of upcoming catalyst events in the biotechnology sector with expert commentary, email & text alerts, plus a portfolio of summary full of tips and insights

LEARN MORE >
Best for Busy Professionals

Biotech Investor

$1,999 / yearly

With our long-term trading program you’ll also receive a watch list of upcoming catalyst events in the biotech sector, a portfolio summary, plus email & text alerts for every trade we make

LEARN MORE >
Best for Committed Traders

Biotech Nucleus

$5,999 / yearly

With this program you‘ll get VIP attention from Kyle Dennis along with both our Catalyst Swing Trading and Long-Term Trading programs, plus video watch lists ,video portfolio summaries, plus private & semi-private mentoring to accelerate your success

LEARN MORE >

I’m an expert at finding winning Biotech trades

Let me show you how to discover, track and evaluate today’s hottest Biotech companies, so you can start trading their stocks for exceptional profits

icon-training

Exceptional
Training

icon-stock-picks

Exceptional
Stock Picks

icon-stock-picks

Exceptional
Mentorship

BioTech Breakouts is built on a proven track record of success and verified trading profits

Here are just a few of my recent winning trades

BSPM + $11,747
BCLI + $8,911
ARLZ + $4,099
SGYP + $7,454
NYMX + $14,261
EBIO + $6,060
GNCA + $11,101
SUPN + $5,651
ILMN + $5,552
KOOL + $9,049

Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Verified profits from the portfolio Kyle Dennis manages.

3 reasons why I’m 100% focused on Biotech stocks

1. Outperformance

Over the last 5 years, biotech has drastically outperformed the S&P 500. The biotech index is up over 200%, while the S&P index is up about 90%.

2. Acquisitions

Large cap Biotech companies continue to grow through acquisition of developmental Biotech companies. The large cap companies have a ton of cash that they’ve been putting to work.

Here are a few examples:


Vitae Pharma was acquired by Allergan in an all-cash deal valued at about $639 million




Medivation was acquired by Pfizer for $14 billion





Cynapsus Therapuetics was purchased for $40.50 a share by Sunovion Pharmaceuticals.




3. Binary events

Biotech companies have binary events that can not only change lives, but make people fortunes. Since these biotech stocks can have such huge gains on a data release, they usually trend higher as the date approaches. As a trader, we can take advantage of this and capture large gains without taking the risk of holding through data.

Ready to grab your share of the profits?

Meet Kyle Dennis

Co-Founder and Director of BioTech Breakouts

With a strong background in science, finance, and technical charting, Kyle Dennis is uniquely qualified to put together high-potential BioTech trading opportunities.

He continually scans the market for the best catalysts, looks into a company’s financial filings to uncover the inside scoop of what it is doing with its capital.

He evaluates how the company is structured taking into account important factors like warrants, compensation, etc, and then calculates what kind of price movement to expect.

These critical aspects of small-cap trading are typically overlooked by the vast majority of traders and investors. Especially beginners.

By taking this time-tested, systematic approach, Kyle creates a unique synergy of these 3 key aspects to deliver his clients and subscribers trading opportunities that offer a high probablity of success with favorable risk to reward ratios.

BioTech is today’s most explosive sector for smart stock traders. Join today, and let’s grow your wealth

Best for Active Traders

Biotech Catalyst Swing Trading

$399 / quarterly

Each week you’ll receive a watch list of upcoming catalyst events in the biotechnology sector with expert commentary, email & text alerts, plus a portfolio of summary full of tips and insights

LEARN MORE >
Best for Busy Professionals

Biotech Investor

$1,999 / yearly

With our long-term trading program you’ll also receive a watch list of upcoming catalyst events in the biotech sector, a portfolio summary, plus email & text alerts for every trade we make

LEARN MORE >
Best for Committed Traders

Biotech Nucleus

$5,999 / yearly

With this program you‘ll get VIP attention from Kyle Dennis along with both our Catalyst Swing Trading and Long-Term Trading programs, plus video watch lists ,video portfolio summaries, plus private & semi-private mentoring to accelerate your success

LEARN MORE >

Start trading with me today – I do the work, find, and reveal the best Biotech trades each week with upside potential for exceptional, wealth-building gains.

Learn my system. Trade my system. You keep the profits.

What other top traders are saying about Kyle Dennis and BioTech Breakouts

Jason Bond

I've had the privilege of trading alongside Kyle for nearly 3 years now. In that time I've seen him grow a $15,000 account to nearly $2 million at the age of 26. He's an amazing trader and wonderful teacher of trading as well. He's spent countless hours teaching Jason Bond Picks clients and has a big following in my service.

Jeff Bishop

One of the first trade alerts I got from Kyle was on biotech stocks MRNS and BLRX a few weeks ago. After doing my own research, I bought both of them with a speculative bet of $24k. In less than a month I'm now sitting on OVER $35,000 on these trades. Thanks so much Kyle! Keep them coming!!!

Why wait and delay your success and profits? Join BioTech Breakouts today, and let’s take your trading to the next level